» Articles » PMID: 21995507

Health-related Quality of Life After Radical Retropubic Prostatectomy and Permanent Prostate Brachytherapy: a 3-year Follow-up Study

Overview
Journal Int J Urol
Specialty Urology
Date 2011 Oct 15
PMID 21995507
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To examine quality of life (QOL) for 3 years after radical retropubic prostatectomy (RRP) or permanent prostate brachytherapy (PPB) and to determine differences between the two procedures.

Methods: In all 107 patients who underwent RRP and 91 who received PPB between October 2005 and July 2007 were included in this study. QOL surveys were performed using the international prostate symptom score (IPSS), the Medical Outcome Study 8-items short form health survey and the expanded prostate cancer index composite at baseline and 1, 3, 6, 12 and 36 months after treatment.

Results: At 3 years, all parameters for general QOL and almost all for disease-specific QOL were similar to those at 12 months. Urinary continence after RRP slightly improved from 12 months to 3 years, but it was still significantly worse than that after PPB. Scores for urinary irritation or obstruction and for bowel function and bother at 3 years were similar between the two groups. Sexual function and bother did not change between 12 months and 3 years in either group. Sexual function at 3 years after RRP was worse than that after PPB. Recovery from urinary incontinence and sexual function after RRP with nerve sparing were similar to those after PPB. Urinary incontinence at 3 years correlated with the treatment method and patients' age, whereas urinary irritation/obstruction and urinary bother correlated with the pre-treatment IPSS.

Conclusion: QOL assessment represents an important issue in prostate cancer management. Our findings are likely to be of aid in the development of a treatment plan for prostate cancer patients.

Citing Articles

Health-related quality of life after robot-assisted radical prostatectomy compared with laparoscopic radical prostatectomy.

Koike H, Kohjimoto Y, Iba A, Kikkawa K, Yamashita S, Iguchi T J Robot Surg. 2017; 11(3):325-331.

PMID: 28130703 DOI: 10.1007/s11701-016-0659-8.


Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol.

Fernandez Ots A, Bucci J, Chin Y, Malouf D, Howie A, Enari K JMIR Res Protoc. 2016; 5(2):e98.

PMID: 27296781 PMC: 4923592. DOI: 10.2196/resprot.5433.


Health-related quality of life following radical prostatectomy: long-term outcomes.

Matthew A, Alibhai S, Davidson T, Currie K, Jiang H, Krahn M Qual Life Res. 2014; 23(8):2309-17.

PMID: 24609438 DOI: 10.1007/s11136-014-0664-1.


Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer.

Yamamoto S, Fujii Y, Masuda H, Urakami S, Saito K, Kozuka T Qual Life Res. 2013; 23(5):1641-50.

PMID: 24338068 PMC: 4031389. DOI: 10.1007/s11136-013-0603-6.


Longitudinal comparison of quality of life after real-time tumor-tracking intensity-modulated radiation therapy and radical prostatectomy in patients with localized prostate cancer.

Shinohara N, Maruyama S, Shimizu S, Nishioka K, Abe T, C-Hatanaka K J Radiat Res. 2013; 54(6):1095-101.

PMID: 23660274 PMC: 3823776. DOI: 10.1093/jrr/rrt049.